A coffee drinking habit has been linked with lower risks of heart disease, dementia, diabetes and overall better health. Now, a new study has shown that when it comes to health benefits, drinking... ...
Improved patterns of anti-diabetic medication use and declining rates of various life-threatening acute diabetes complications are closing the disparities gap for American Indian and Alaska Native populations with Type 2 diabetes.
Millions of people with diabetes track their glucose levels daily using finger-stick devices that draw and analyze their blood. But what if they could monitor it with just a sweat sensor? That’s the idea behind new research from Binghamton University, State University of New York that could revolutionize diabetes management by eliminating the pain and hassle.
According to a report from the Indiana University Center for Rural Engagement, 70 percent of counties in the Indiana Uplands region have identified access to health care as a top community need.
A study led by the University of California, Irvine has found cardiovascular conditions such as high blood pressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an increased risk of such harm in individuals 90 and older.
Two UdeM professors have co-authored and published the first Canadian guidelines for better detection, management and treatment of cystic fibrosis-related diabetes.
“Findings from the ongoing research, including dozens of related studies that build off the cohort, are influencing clinical care and prevention strategies,” said Frank Penedo, Ph.D., principal investigator for the study.
Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic polypeptide receptor (GIPR) lost more than a third of their body weight through a mechanism that burns energy, UT Southwestern Medical Center researchers report in a new study. Published in Cell Metabolism, the findings highlight the potential of GIPR – a protein thought of as a minor player in a class of popular weight-loss drugs – to have its own starring role in therapies to fight obesity.
Study published in Nature Medicine estimates that 2.2 million new cases of type 2 diabetes and 1.2 million new cases of cardiovascular disease occur each year globally due to consumption of sugar-sweetened beverages.
Researchers at the University of Michigan evaluated the uptake and outcomes of the National DPP using surveys from 5,948 university employees, dependents and retirees with prediabetes over two years.
The holidays bring joy, but also potential challenges for people managing diabetes. Unlike the rest of the year, the holidays mean more food, especially goodies laden with sugar.
Las fiestas traen alegrĂa, pero tambiĂ©n desafĂos potenciales para las personas con diabetes. A diferencia del resto del año, las fiestas significan más comida, especialmente golosinas cargadas de azĂşcar. La Dr. Lorena AlarcĂłn-Casas Wright, endocrinĂłloga de Medicina de la Universidad de Washington, ofrece consejos prácticos para afrontar esta temporada festiva mientras mantiene bajo control los niveles de azĂşcar en la sangre. "Cuanto más activos seamos, más sanos seremos y mejor será nuestro nivel de azĂşcar en la sangre", afirmĂł. "Piense en la moderaciĂłn, observe las porciones, tenga en cuenta... Âżrealmente necesito comer esto?" Wright anima a las personas con diabetes a controlar el nivel de azĂşcar en sangre antes de los eventos festivos y a mantenerse activas. Esas pequeñas consideraciones, afirma, pueden permitir que las personas con diabetes disfruten de la temporada con sus amigos y familiares Descargue fragmentos de sonido listos para transmitir y contenido m
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites. The differences could not be fully explained by income or education level, health insurance coverage or clinical need.
Involving local leaders and churches could make all the difference in rural communities in diabetes prevention, according to a recent study from the University of Georgia.
A multidisciplinary team led by Ken Shepard, a pioneering researcher in bioelectronics at Columbia Engineering, has won an award of up to $41 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a wireless bioelectronic device to treat obesity and diabetes. The team was selected by ARPA-H’s Resilient Extended Automatic Cell Therapies (REACT) program to create bioelectronic devices that enable people to administer treatments of biologic drugs without the need for injections. Instead, engineered cells act as cell factories to produce the drugs, negating the need for the chemical modifications required to make such biologics shelf-stable, which often results in reduced efficacy.
Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new understanding of how human beta cell regenerative drugs work.
In November, Lurie Children’s and Northwestern University co-hosted the 2024 T1D Exchange Learning Session in Chicago. The T1D Exchange Quality Improvement Collaborative (QIC) brings together clinics across the United States, connecting experts that collectively treat over 100,000 individuals with Type 1 diabetes.
New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug therapies preventing the disease’s progression into end stage kidney failure.
Scientists have developed an innovative glucose-responsive membrane capable of self-regulating insulin release, offering a potential revolution in diabetes management. This cutting-edge material responds to glucose levels by contracting, functioning as an automatic chemical valve that controls insulin delivery.
A research team from The Ohio State University Wexner Medical Center and College of Medicine will study approaches to postpartum blood pressure control among Ohio patients, as part of a $12.5 million three-state study.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
